首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1735612

全球伴侶動物保健市場規模（按類型、產品、分銷管道、最終用戶、區域覆蓋範圍和預測）

Global Companion Animal Health Market Size By Type, By Product, By Distribution Channel, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

伴侶動物保健市場規模及預測

2024 年伴侶動物保健市場規模價值為 224.8 億美元，預計到 2032 年將達到 431.4 億美元，2026 年至 2032 年的複合年成長率為 8.49%。

伴侶動物健康涉及對寵物進行定期監測和護理，以發現和治療若不及時治療可能危及生命的疾病和病症。該領域涵蓋了廣泛的進展，包括基因組診斷、數位技術、抗癌藥物、治療性疫苗和單株抗體療法。
這些創新對於實現更早的診斷和更有效的治療至關重要，從而為伴侶動物帶來更好的治療結果。
近年來，越來越多的飼主開始關注寵物的整體健康和福祉。這些更了解情況的飼主積極尋求獸醫護理，以維護寵物的健康，從而促進了伴侶動物保健產業的發展。
對預防性護理和先進治療的關注反映了改善寵物生活品質的更廣泛趨勢，類似於人類醫療保健的進步。
隨著全球寵物飼養人口的持續成長，對創新醫療解決方案和更便利獸醫服務的需求不斷成長，預計伴侶動物健康市場將進一步擴張。人們對伴侶動物健康的日益關注，凸顯了早期療育和全面照護對寵物健康的重要性。

全球伴侶動物保健市場動態

影響全球伴侶動物保健市場的關鍵市場動態是：

關鍵市場促進因素

全球寵物擁有量不斷成長：全球寵物擁有量不斷成長是伴侶動物保健市場的主要驅動力，因為寵物數量的增加導致對獸醫護理和保健產品的需求增加。根據美國寵物產品協會 (APPA) 2021-2022 年全國寵物主人調查，70% 的美國家庭擁有寵物，相當於 9,050 萬戶家庭。
寵物醫療保健支出增加：寵物飼主越來越願意在寵物健康上投入更多資金，這推動了伴侶動物保健市場的成長。根據美國寵物產品協會的報告，2020年美國在獸醫護理和產品上的支出為314億美元，預計到2021年將達到323億美元。
通用感染疾病的傳播：人畜共通感染疾病（可在動物和人類之間傳播的疾病）的增加，推動了對更優質的伴侶動物醫療產品和服務的需求。根據世界衛生組織 (WHO) 的數據，約 60% 的已知人類感染疾病和 75% 的新型或新興感染疾病感染疾病人畜共通傳染病。

主要挑戰

獸醫護理和治療費用不斷上漲：獸醫服務和動物用藥品成本的上漲對許多飼主來說可能是一個重大障礙，並限制了市場的成長。根據美國獸醫協會 (AVMA) 的數據，2016 年每戶家庭的平均獸醫護理費用為：狗 410 美元，貓 275 美元。根據美國寵物產品協會 (APPA) 的報告，獸醫護理費用正在穩步上升，美國寵物行業的總支出將從 2018 年的 905 億美元增至 2020 年的 1,036 億美元。
獸醫專業人員短缺：合格獸醫和獸醫技術人員的短缺可能會限制動物保健服務的可及性，並抑制市場成長。美國勞工統計局預測，從2020年到2030年，獸醫的就業人數將成長17%，遠高於所有職業的平均成長速度。然而，這種成長速度仍趕不上需求。瑪氏獸醫健康公司2019年的一項研究預測，到2030年，美國獸醫將短缺7.5萬名，這表明供需之間存在巨大缺口。
嚴格的動物用藥品監管核准：嚴格的監管和冗長的核准流程可能會減緩新治療方法的創新和市場准入。美國食品藥物管理局(FDA)動物用藥品中心 (CVM) 報告稱，2020 會計年度，核准新動物用藥品動物用藥品申請 (NADA) 的平均時間為 295 天。

主要趨勢

遠端醫療在獸醫護理中的應用日益廣泛：遠端醫療在獸醫護理中的應用正在迅速擴展，為寵物飼主提供了便捷的獸醫諮詢和後續觀察。美國獸醫協會 (AVMA) 2020 年的一項調查發現，在新冠疫情期間，32% 的獸醫診所正在使用遠距醫療服務。美國動物醫院協會 (AAHA) 報告稱，30% 的寵物飼主有興趣使用遠端醫療服務來滿足其寵物的醫療保健需求。
寵物穿戴式裝置和健康監測設備市場不斷成長：寵物照護技術融合，尤其是穿戴式裝置和健康監測工具，是伴侶動物健康市場的新興趨勢。
個人化和預防性獸醫學的興起：伴侶動物健康正呈現個人化和預防性醫療的成長趨勢，包括基因檢測和客製化營養計畫。

Companion animal health involves the regular monitoring and care of pets to detect and treat illnesses or disorders that could threaten their lives if left untreated. This field encompasses a wide range of advancements, including genomic diagnostics, digital technologies, anti-cancer medications, therapeutic vaccines, and monoclonal antibody therapies.
These innovations are critical for early diagnosis and effective treatment, ensuring better outcomes for companion animals.
In recent years, there has been a notable rise in the number of pet owners who are increasingly aware of their pets' overall health and welfare. These informed pet owners actively seek veterinary care to maintain their pets' well-being, contributing to the growth of the companion animal health sector.
The focus on preventive care and advanced treatments reflects a broader trend towards enhancing the quality of life for pets, paralleling similar advancements in human healthcare.
As the global population of pet owners continues to grow, the companion animal health market is expected to expand further, driven by increased demand for innovative healthcare solutions and more accessible veterinary services. This growing focus on companion animal health highlights the importance of early intervention and comprehensive care for the well-being of pets.

Global Companion Animal Health Market Dynamics

The key market dynamics that are shaping the global companion animal health market include:

Key Market Drivers

Increasing Pet Ownership Rates Globally: The growing number of pet owners worldwide is a key driver for the companion animal health market, as more pets lead to higher demand for veterinary care and health products. According to the American Pet Products Association's (APPA) 2021-2022 National Pet Owners Survey, 70% of U.S. households own a pet, which equates to 90.5 million homes.
Rising Expenditure on Pet Healthcare: Pet owners are increasingly willing to spend more on their pets' health, driving growth in the companion animal health market. The American Pet Products Association reports that in 2020, Americans spent USD 31.4 Billion on veterinary care and products, and this figure is estimated to have reached USD 32.3 Billion in 2021.
Growing Prevalence of Zoonotic Diseases: The increasing occurrence of zoonotic diseases (diseases that can be transmitted between animals and humans) is driving demand for better companion animal health products and services. According to the World Health Organization (WHO), approximately 60% of known infectious diseases in humans and 75% of new or emerging infectious diseases are zoonotic.

Key Challenges

High Cost of Veterinary Care and Treatments: The increasing cost of veterinary services and animal health products can be a significant barrier for many pet owners, potentially limiting market growth. According to the American Veterinary Medical Association (AVMA), the average veterinary expenditure per household for dogs was $410 in 2016, while for cats it was $275. The American Pet Products Association (APPA) reports that veterinary care costs have been steadily rising, with total U.S. pet industry expenditures increasing from USD 90.5 Billion in 2018 to USD 103.6 Billion in 2020.
Shortage Of Veterinary Professionals: A lack of qualified veterinarians and veterinary technicians can limit access to animal healthcare services, restraining market growth. The U.S. Bureau of Labor Statistics projects that employment of veterinarians will grow 17% from 2020 to 2030, much faster than the average for all occupations. However, this growth is not keeping pace with demand. A 2019 study by Mars Veterinary Health predicted a shortage of 75,000 veterinarians in the U.S. by 2030, indicating a significant gap between supply and demand.
Stringent Regulatory Approvals for Animal Health Products: Strict regulations and lengthy approval processes for new animal health products can slow down innovation and market entry for new treatments. The U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) reports that the average time for approval of a new animal drug application (NADA) was 295 days in fiscal year 2020.

Key Trends

Increasing Adoption of Telemedicine in Veterinary Care: The use of telemedicine in veterinary practice is growing rapidly, offering pet owners convenient access to veterinary consultations and follow-ups. According to a survey by the American Veterinary Medical Association (AVMA) in 2020, 32% of veterinary practices were using telemedicine to provide care during the COVID-19 pandemic. The American Animal Hospital Association (AAHA) reports that 30% of pet owners expressed interest in using telemedicine services for their pets' healthcare needs.
The Growing Market for Pet Wearables and Health Monitoring Devices: The integration of technology in pet care, particularly through wearable devices and health monitoring tools, is an emerging trend in the companion animal health market.
Rise in Personalized and Preventive Veterinary Medicine: There's a growing trend towards personalized and preventive care in companion animal health, including genetic testing and tailored nutrition plans.

Global Companion Animal Health Market Regional Analysis

Here is a more detailed regional analysis of the global companion animal health market:

Europe

Europe substantially dominates the global companion animal health market owing to the high pet ownership rates and increasing pet humanization.
Europe has one of the highest pet ownership rates globally, with a growing trend of treating pets as family members, leading to increased spending on pet health.
According to the European Pet Food Industry Federation (FEDIAF), as of 2021, 88 million households in the EU own a pet. This represents 46% of all households in the EU. Dogs are the most popular, with 90 million dogs in European households.
Europe boasts a well-developed veterinary healthcare system, with a high number of veterinary professionals and advanced facilities.
The Federation of Veterinarians of Europe (FVE) reports that as of 2019, there were approximately 309,000 veterinarians in Europe, with a ratio of about 1 veterinarian per 2,000 inhabitants. This high density of veterinary professionals contributes to better access to pet healthcare services.
European countries have some of the world's most comprehensive animal welfare laws, driving demand for high-quality pet healthcare products and services.
The European Union has implemented various regulations to ensure animal welfare, including Regulation (EU) 2019/6 on veterinary medicinal products, which came into effect in January 2022.

North America

North America is anticipated to witness the fastest growth in the global companion animal health market during the forecast period driven by the increasing pet expenditure.
North America, particularly the United States, has one of the highest pet ownership rates globally, with significant spending on pet health and wellness.
According to the American Pet Products Association (APPA) 2021-2022 National Pet Owners Survey, 70% of U.S. households own a pet, which equates to about 90.5 million homes. The same survey reports that Americans spent $123.6 billion on their pets in 2021, with USD 34.3 Billion specifically on veterinary care and product sales.
Advanced veterinary healthcare infrastructure and technology adoption. North America boasts a highly developed veterinary healthcare system with widespread adoption of advanced technologies.
The American Veterinary Medical Association (AVMA) reports that as of 2021, there were approximately 120,652 veterinarians in the United States.
Increasing prevalence of chronic diseases in pets: The rising incidence of chronic diseases in companion animals is driving demand for advanced treatments and long-term care.
According to Banfield Pet Hospital's 2020 Veterinary Emerging Topics (VET) Report, chronic kidney disease diagnoses in cats increased by 31% from 2009 to 2019. The same report noted that 51% of dogs and 44% of cats in the U.S. were classified as overweight or obese in 2019, conditions that can lead to various chronic health issues requiring ongoing medical care.

Global Companion Animal Health Market: Segmentation Analysis

The Global Companion Animal Health Market is segmented based on Type, Product, Distribution Channel, End-User, And Geography.

Companion Animal Health Market, By Type

Dogs
Cats
Equine

Based on the Type, the Global Companion Animal Health Market is bifurcated into Dogs, Cats, and Equine. The dog segment dominates the global companion animal health market, fueled by increasing awareness of pet health insurance among dog owners. A growing number of covered dogs reflects this trend, as more owners acknowledge the financial benefits and protection that pet insurance offers. This shift alleviates the high costs associated with veterinary services and encourages regular veterinary visits and preventive care.

Companion Animal Health Market, By Product

Therapeutics
Diagnostics
Vaccines
Pharmaceuticals
OTC

Based on the Product, the Global Companion Animal Health Market is bifurcated into Therapeutics, Diagnostics, Vaccine, Pharmaceuticals, and OTC. The pharmaceuticals segment dominates the global companion animal health market owing to the rising prevalence of food-borne diseases, brucellosis, and zoonotic diseases that pose significant risks to animals, creating an urgent need for effective medications. Additionally, the substantial increase in animal bite incidents heightens the risk of disease transmission and microbial infections, further driving demand for pharmaceuticals.

Companion Animal Health Market, By Distribution Channel

Retail
E-Commerce
Hospital Pharmacies

Based on the Distribution Channel, the Global Companion Animal Health Market is bifurcated into Retail, E-Commerce, and Hospital Pharmacies. The hospital pharmacies segment dominates the global companion animal health market, driven by the rising prevalence of chronic diseases and various epidemics affecting pets. Hospitals offer advanced treatment products that contribute significantly to this segment's growth. The high procedural volume, stemming from frequent readmissions of pets for ongoing treatment, further supports this trend.

Companion Animal Health Market, By End-User

In House Testing
Veterinary Hospitals and Clinics
Reference Laboratories

Based on End-User, the Global Companion Animal Health Market is bifurcated into In-House Testing, Veterinary Hospitals and Clinics, and Reference Laboratories. The veterinary hospitals and clinics segment significantly dominates in the global companion animal health market, driven by various applications such as therapy, toxicological testing, and clinical pathology. This segment's growth is significantly influenced by the availability of certain vaccines exclusively at accredited veterinary facilities. Additionally, recent years have seen an expansion of opportunities for this segment, as numerous government and animal welfare organizations have implemented regulations and standards for safety practices in veterinary hospitals and clinics.

Companion Animal Health Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the Global Companion Animal Health Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Europe substantially dominates the global companion animal health market owing to the high pet ownership rates and increasing pet humanization. Europe has one of the highest pet ownership rates globally, with a growing trend of treating pets as family members, leading to increased spending on pet health. According to the European Pet Food Industry Federation (FEDIAF), as of 2021, 88 million households in the EU own a pet. This represents 46% of all households in the EU. Dogs are the most popular, with 90 million dogs in European households. Europe boasts a well-developed veterinary healthcare system, with a high number of veterinary professionals and advanced facilities.

Key Players

The "Global Companion Animal Health Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, IDEXX Laboratories, Inc., Elanco, Indian Immunologicals Ltd., Virbac, Agrolabo SpA, Norbrook.

This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Companion Animal Health Market Key Developments

In June 2023, Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, announced today that the European Commission has approved INNOVAX(R)-ILT-IBD, a dual-construct HVT vaccine that provides long-term protection against infectious laryngotracheitis (ILT), infectious bursal disease (IBD), and Marek's disease (MD).
In May 2023, Merck Animal Health announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) had approved a novel injectable formulation of BRAVECTO(R) (fluralaner) for the treatment and prevention of flea (Ctenocephalides felis) infestations for 12 months, control of paralysis tick (Ixodes holocyclus) for 12 months, control of brown dog tick (Rhipicephalus sanguineus) for 11 months, and control of flea allergy dermatitis.

1 INTRODUCTION OF GLOBAL COMPANION ANIMAL HEALTH MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL COMPANION ANIMAL HEALTH MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY TYPE

5.1 Overview
5.2 Dogs
5.2 Cats
5.3 Equine

6 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY PRODUCT

6.1 Overview
6.2 Therapeutics
6.3 Diagnostics
6.4 Vaccines
6.5 Pharmaceuticals

OTC7 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY DISTRIBUTION CHANNEL

7.1 Overview
7.2 Retail
7.3 E-Commerce
7.4 Hospital Pharmacies

8 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY END USER

8.1 Overview
8.2 In House Testing
8.3 Veterinary Hospitals and Clinics
8.4 Reference Laboratories

9 GLOBAL COMPANION ANIMAL HEALTH MARKET, BY GEOGRAPHY

9.1. Overview
9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
- 9.2.3. Mexico
9.3. Europe
- 9.3.1. Germany
- 9.3.2. U.K.
- 9.3.3. France
- 9.3.4. Rest of Europe
9.4. Asia Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. Rest of Asia Pacific
9.5. Rest of the World
- 9.5.1. Latin America
- 9.5.2. Middle East & Africa

10 GLOBAL COMPANION ANIMAL HEALTH MARKET COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 Merck & Co., Inc.
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Ceva
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Vetoquinol S.A.
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 Zoetis
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Boehringer Ingelheim GmbH
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 IDEXX Laboratories, Inc.
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Elanco
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 Indian Immunologicals Ltd.
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments
11.9 Virbac
- 11.9.1 Overview
- 11.9.2 Financial Performance
- 11.9.3 Product Outlook
- 11.9.4 Key Developments
11.10 Agrolabo SpA,
- 11.10.1 Overview
- 11.10.2 Financial Performance
- 11.10.3 Product Outlook
- 11.10.4 Key Developments
11.11 Norbrook
- 11.11.1 Overview
- 11.11.2 Financial Performance
- 11.11.3 Product Outlook
- 11.11.4 Key Developments